SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
Emblem insulin formulary_change_2010
Emblem insulin formulary_change_2010

Contenu connexe

Plus de sstrumello

Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdf
Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdfAmphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdf
Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdfsstrumello
 
JDRF-Civica Rx Insulin-Announcement
JDRF-Civica Rx Insulin-AnnouncementJDRF-Civica Rx Insulin-Announcement
JDRF-Civica Rx Insulin-Announcementsstrumello
 
JDRF-Civica Insulin Announcement Fact Sheet
JDRF-Civica Insulin Announcement Fact SheetJDRF-Civica Insulin Announcement Fact Sheet
JDRF-Civica Insulin Announcement Fact Sheetsstrumello
 
Right Care Alliance Presentation
Right Care Alliance PresentationRight Care Alliance Presentation
Right Care Alliance Presentationsstrumello
 
1992 Heritage Consumer Choice Health Plan
1992 Heritage Consumer Choice Health Plan1992 Heritage Consumer Choice Health Plan
1992 Heritage Consumer Choice Health Plansstrumello
 
Biodel, Inc. Investor Presentation January 14, 2010
Biodel, Inc. Investor Presentation January 14, 2010Biodel, Inc. Investor Presentation January 14, 2010
Biodel, Inc. Investor Presentation January 14, 2010sstrumello
 
Pet contest winners
Pet contest winnersPet contest winners
Pet contest winnerssstrumello
 
JDRF Countdown July 2009
JDRF Countdown July 2009JDRF Countdown July 2009
JDRF Countdown July 2009sstrumello
 
Bentley (College) University Society Monthly Review
Bentley (College) University Society Monthly ReviewBentley (College) University Society Monthly Review
Bentley (College) University Society Monthly Reviewsstrumello
 
Treatment of patients with new onset Type 1 diabetes with a single course of ...
Treatment of patients with new onset Type 1 diabetes with a single course of ...Treatment of patients with new onset Type 1 diabetes with a single course of ...
Treatment of patients with new onset Type 1 diabetes with a single course of ...sstrumello
 
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...sstrumello
 
Stanford University Case Study: Novo Nordisk
Stanford University Case Study: Novo NordiskStanford University Case Study: Novo Nordisk
Stanford University Case Study: Novo Nordisksstrumello
 
Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?sstrumello
 
Mr. Hypo Is My Friend
Mr. Hypo Is My FriendMr. Hypo Is My Friend
Mr. Hypo Is My Friendsstrumello
 
Different Potencies of Biosynthetic Human and Purified Porcine Insulin
Different Potencies of Biosynthetic Human and Purified Porcine InsulinDifferent Potencies of Biosynthetic Human and Purified Porcine Insulin
Different Potencies of Biosynthetic Human and Purified Porcine Insulinsstrumello
 

Plus de sstrumello (15)

Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdf
Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdfAmphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdf
Amphastar Pharmaceuticals Sep 2022 Corp Presentation-Insulin Biosims.pdf
 
JDRF-Civica Rx Insulin-Announcement
JDRF-Civica Rx Insulin-AnnouncementJDRF-Civica Rx Insulin-Announcement
JDRF-Civica Rx Insulin-Announcement
 
JDRF-Civica Insulin Announcement Fact Sheet
JDRF-Civica Insulin Announcement Fact SheetJDRF-Civica Insulin Announcement Fact Sheet
JDRF-Civica Insulin Announcement Fact Sheet
 
Right Care Alliance Presentation
Right Care Alliance PresentationRight Care Alliance Presentation
Right Care Alliance Presentation
 
1992 Heritage Consumer Choice Health Plan
1992 Heritage Consumer Choice Health Plan1992 Heritage Consumer Choice Health Plan
1992 Heritage Consumer Choice Health Plan
 
Biodel, Inc. Investor Presentation January 14, 2010
Biodel, Inc. Investor Presentation January 14, 2010Biodel, Inc. Investor Presentation January 14, 2010
Biodel, Inc. Investor Presentation January 14, 2010
 
Pet contest winners
Pet contest winnersPet contest winners
Pet contest winners
 
JDRF Countdown July 2009
JDRF Countdown July 2009JDRF Countdown July 2009
JDRF Countdown July 2009
 
Bentley (College) University Society Monthly Review
Bentley (College) University Society Monthly ReviewBentley (College) University Society Monthly Review
Bentley (College) University Society Monthly Review
 
Treatment of patients with new onset Type 1 diabetes with a single course of ...
Treatment of patients with new onset Type 1 diabetes with a single course of ...Treatment of patients with new onset Type 1 diabetes with a single course of ...
Treatment of patients with new onset Type 1 diabetes with a single course of ...
 
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings o...
 
Stanford University Case Study: Novo Nordisk
Stanford University Case Study: Novo NordiskStanford University Case Study: Novo Nordisk
Stanford University Case Study: Novo Nordisk
 
Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?
 
Mr. Hypo Is My Friend
Mr. Hypo Is My FriendMr. Hypo Is My Friend
Mr. Hypo Is My Friend
 
Different Potencies of Biosynthetic Human and Purified Porcine Insulin
Different Potencies of Biosynthetic Human and Purified Porcine InsulinDifferent Potencies of Biosynthetic Human and Purified Porcine Insulin
Different Potencies of Biosynthetic Human and Purified Porcine Insulin